Pacific Northwest Diabetes Research Institute (PNDRI) announced today that John Wecker, PhD has been appointed president and CEO.
Dr. Wecker was most recently Global Program Leader, Vaccine Access and Delivery at PATH.
PNDRI is an independent non-profit biomedical and clinical research center that focuses on eliminating diabetes and its complications.
The Institute, which has a team of 85 physicians, scientists and technical staff, was founded in Seattle in 1956 by Dr. William Hutchinson, Sr., who also founded the Fred Hutchinson Cancer Research Center.
Before he joined PATH, Dr. Wecker worked for Boehringer Ingelheim, a global pharmaceutical company, where he led pharmaceutical product development teams and championed the company’s efforts to expand access to treatments for HIV/AIDS in the developing world.
During this time he established a program to provide medication for the prevention of mother-child transmission of HIV/AIDS, free of charge to over 120 countries around the world.
Dr. Wecker received his doctorate in Biological Psychology from the University of Rochester, Rochester, NY.
Dr. Wecker succeeds Dr. Jack Faris, who has been serving as acting CEO during the past eighteen months. Dr. Faris will remain part of the PNDRI team as a strategic advisor.
Dr. Wecker will begin at PNDRI on April 23rd.
To learn more:
- For more information about PNDRI, visit www.pndri.org or call (206) 726-1200.